Key result
Myocardial disarray is a hallmark of hypertrophic cardiomyopathy, but its specific role as an independent driver of ventricular arrhythmias and sudden cardiac death remains controversial.
Why the study?
Controversy persists regarding the diagnostic value and arrhythmogenic risk of myocardial disarray in hypertrophic cardiomyopathy, necessitating clarification of its functional consequences, quantity, and relation to sudden death.
Myocardial disarray is a key histopathological feature of HCM that may contribute to arrhythmogenesis and sudden cardiac death, with emerging imaging techniques like DT-CMR allowing for its in vivo quantification.
Myocardial disarray assessment should not yet inform SCD risk stratification in HCM; leaves open its independent arrhythmogenic role for prospective validation.
Myocardial disarray is defined as disorganized cardiomyocyte spatial distribution, with loss of physiological fibre alignment and orientation. Since the first pathological descriptions of hypertrophic cardiomyopathy (HCM), disarray appeared as a typical feature of this condition and sparked vivid debate regarding its specificity to the disease and clinical significance as a diagnostic marker and a risk factor for sudden death. Although much of the controversy surrounding its diagnostic value in HCM persists, it is increasingly recognized that myocardial disarray may be found in physiological contexts and in cardiac conditions different from HCM, raising the possibility that central focus should be placed on its quantity and distribution, rather than a mere presence. While further studies are needed to establish what amount of disarray should be considered as a hallmark of the disease, novel experimental approaches and emerging imaging techniques for the first time allow ex vivo and in vivo characterization of the myocardium to a molecular level. Such advances hold the promise of filling major gaps in our understanding of the functional consequences of myocardial disarray in HCM and specifically on arrhythmogenic propensity and as a risk factor for sudden death. Ultimately, these studies will clarify whether disarray represents a major determinant of the HCM clinical profile, and a potential therapeutic target, as opposed to an intriguing but largely innocent bystander.
No takes yet. Share an insight, caveat, or question.
Finocchiaro et al. (2020) conducted a review in Hypertrophic cardiomyopathy. Myocardial disarray was evaluated. Myocardial disarray is a hallmark of hypertrophic cardiomyopathy, but its specific role as an independent driver of ventricular arrhythmias and sudden cardiac death remains controversial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: